Opdivo approved for subtype of colorectal cancer
From 5% to 15% of people colorectal cancer have the MSI-H subtype CANCER DIGEST – April 12, 2025 – The FDA this week approved another...


Immunotherapy breakthrough in bladder cancer
CANCER DIGEST – Nov. 25, 2023 – A large Dutch trial confirms the results of a US study showing the addition of immunotherapy to...
